JPMorgan Chase & Co’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39 | Buy |
12
+1
| +9% | +$3 | ﹤0.01% | 6021 |
|
|
2025
Q1 | $31 | Sell |
11
-2
| -15% | -$6 | ﹤0.01% | 6180 |
|
|
2024
Q4 | $222 | Hold |
13
| – | – | ﹤0.01% | 5847 |
|
|
2024
Q3 | $350 | Sell |
13
-51
| -80% | -$1.37K | ﹤0.01% | 5767 |
|
|
2024
Q2 | $2.6K | Buy |
64
+51
| +392% | +$2.07K | ﹤0.01% | 5473 |
|
|
2024
Q1 | $855 | Sell |
13
-73
| -85% | -$4.8K | ﹤0.01% | 5648 |
|
|
2023
Q4 | $9.8K | Sell |
86
-48
| -36% | -$5.47K | ﹤0.01% | 5388 |
|
|
2023
Q3 | $24.3K | Buy |
134
+121
| +931% | +$21.9K | ﹤0.01% | 5103 |
|
|
2023
Q2 | $4.7K | Sell |
13
-384
| -97% | -$139K | ﹤0.01% | 5284 |
|
|
2023
Q1 | $265K | Buy |
397
+103
| +35% | +$68.8K | ﹤0.01% | 4165 |
|
|
2022
Q4 | $257K | Buy |
294
+26
| +10% | +$22.7K | ﹤0.01% | 4093 |
|
|
2022
Q3 | $294K | Buy |
268
+6
| +2% | +$6.58K | ﹤0.01% | 4006 |
|
|
2022
Q2 | $217K | Sell |
262
-104
| -28% | -$86.1K | ﹤0.01% | 4282 |
|
|
2022
Q1 | $567K | Buy |
366
+59
| +19% | +$91.4K | ﹤0.01% | 3932 |
|
|
2021
Q4 | $551K | Buy |
307
+24
| +8% | +$43.1K | ﹤0.01% | 4005 |
|
|
2021
Q3 | $935K | Sell |
283
-6
| -2% | -$19.8K | ﹤0.01% | 3649 |
|
|
2021
Q2 | $1.27M | Buy |
+289
| New | +$1.27M | ﹤0.01% | 3496 |
|
|
2021
Q1 | – | Sell |
-7
| Closed | -$13K | – | 5245 |
|
|
2020
Q4 | $13K | Sell |
7
-105
| -94% | -$195K | ﹤0.01% | 4634 |
|
|
2020
Q3 | $40K | Buy |
+112
| New | +$40K | ﹤0.01% | 4344 |
|